Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.12% | -38.82% | -6.76% | -13.96% | -3.67% |
| Total Depreciation and Amortization | -5.14% | -6.62% | -4.41% | -3.94% | -6.25% |
| Total Amortization of Deferred Charges | -- | -44.16% | -100.00% | -100.00% | -100.00% |
| Total Other Non-Cash Items | 11.61% | 14.74% | 1.90% | 104.28% | 111.74% |
| Change in Net Operating Assets | 1,001.63% | 648.54% | 152.05% | 103.17% | 86.13% |
| Cash from Operations | 74.57% | 19.40% | 10.30% | 6.06% | 2.28% |
| Capital Expenditure | -156.25% | -156.25% | -237.50% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 82.25% | 82.25% | -1,581.25% | -1,243.75% | -- |
| Total Debt Issued | 189.94% | -- | -- | -- | -- |
| Total Debt Repaid | -859.81% | -6.21% | 34.35% | 16.31% | 18.56% |
| Issuance of Common Stock | -67.02% | -72.55% | -69.75% | -68.99% | -21.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -133.33% | 7.64% | -118.19% | -109.06% | -113.59% |
| Cash from Financing | -49.42% | -24.14% | -57.18% | -62.11% | -13.67% |
| Foreign Exchange rate Adjustments | -13,300.00% | -109.26% | -445.65% | 1,460.00% | 102.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.17% | -110.96% | -196.98% | -286.47% | -121.85% |